CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 252 enrolled
Drug / intervention
Vitamin C +prenatal vitamin +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01723696
NCT01723696Phase 3Completed
CompareCT.gov

Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function

Oregon Health and Science University·interventional·Posted Nov 8, 2012·Updated Apr 17, 2019

In Brief

A Phase 3 clinical trial evaluating Vitamin C +prenatal vitamin and Placebo tablet+prenatal vitamin for Pulmonary Function; Newborn, Abnormal and 3 related conditions. Completed, enrolled 252 participants across 2 sites.

Detailed Summary

Vitamin C supplementation (500 mg per day) given to pregnant women who can not quit smoking will improve the pulmonary function tests in their offspring measured at 3 months of age.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Function; Newborn, Abnormal, Infant Wheeze, In-utero Nicotine, Second Hand Smoke
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), Office of Dietary Supplements (ODS)

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 8, 2012
Enrollment StartDec 1, 2012
Primary CompletionApr 1, 2016
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.7 years ago

Interventions

Vitamin C +prenatal vitamindietary

Pregnant smoking women will be randomized to daily vitamin C (500 mg) versus daily placebo

Placebo tablet+prenatal vitamindietary